Form 4: Sylvia McBrinn, BioAtla Director, Reports Acquisition of 16,500 Shares of Common Stock

BioAtla Director Sylvia McBrinn reports the acquisition of 16,500 shares of common stock through a restricted stock unit award.

Summary

• On June 13, 2024, Sylvia McBrinn, a director of BioAtla, Inc. (BCAB), acquired 16,500 shares of common stock.
• The acquisition was through a time-based restricted stock unit (RSU) award.
• The RSU will vest as to 100% of the total number of shares on the earlier of June 13, 2025, or the next Company annual meeting of stockholders, subject to continued service.
• Following the transaction, McBrinn directly owns 35,625 shares of BioAtla common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine disclosure of a director receiving stock, which suggests confidence but doesn't provide strong evidence of significant positive or negative developments.

Positives

• A director acquiring shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting of the RSU is contingent upon the reporting person's continued service with the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell the company's securities. It provides transparency to the market regarding insider activity.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates